-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 GdetzD+lBUIPR0M4vzJN+eVGf2Jr8ZEHLXXy7jx+CO8lq04CFCngb8mIdxGyUVxi
 /UlyeyOCjnb+JJB8Krlifw==

<SEC-DOCUMENT>0001032210-01-000047.txt : 20010123
<SEC-HEADER>0001032210-01-000047.hdr.sgml : 20010123
ACCESSION NUMBER:		0001032210-01-000047
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20010116

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			OXIS INTERNATIONAL INC
		CENTRAL INDEX KEY:			0000109657
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				941620407
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		
		SEC FILE NUMBER:	333-40970
		FILM NUMBER:		1508848

	BUSINESS ADDRESS:	
		STREET 1:		6040 N CUTTER CIRCLE STE 317
		CITY:			PORTLAND
		STATE:			OR
		ZIP:			97217
		BUSINESS PHONE:		5032833911

	MAIL ADDRESS:	
		STREET 1:		6040 N CUTTER CIRCLE STE 317
		CITY:			PORTLAND
		STATE:			OR
		ZIP:			97217

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DDI PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DIAGNOSTIC DATA INC /DE/
		DATE OF NAME CHANGE:	19850312
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>0001.txt
<DESCRIPTION>FORM 424B3
<TEXT>

<PAGE>

                                                      Registration No. 333-40970
                                Filed pursuant to Rule 424(c) and Rule 424(b)(3)
                                   (Filed pursuant to Rule 424(b)(3) voluntarily
                                          because additions are not substantive)

                             PROSPECTUS SUPPLEMENT
              (To Prospectus filed as part of Amendment No. 1 to
           Registration Statement on Form S-3 on December 21, 2000)

                            -----------------------

     This Prospectus Supplement supplements the Prospectus relating to the
resale of 4,360,003 shares of Common Stock, par value $0.001 per share, of OXIS
International, Inc. (the "Company") by certain stockholders of the Company,
which Prospectus was filed as part of the Company's Amendment No. 1 to the
Registration Statement on Form S-3 (Registration No. 333-40970) on December 21,
2000.

     The date of this Prospectus Supplement is January 16, 2001.

                            -----------------------

     The facing page of the Prospectus is hereby amended to read as follows:

                                  "PROSPECTUS

                           OXIS INTERNATIONAL, INC.

              4,360,003 Shares of Common Stock ($0.001 par value)

The Offering:

     Shares of common stock offered by selling stockholders............4,360,003

     Offering Price..........On December 22, 2000, the closing sale price of
                             OXIS common stock on the Nasdaq Stock Market was
                             $ 15/32 per share.

     Nasdaq National Market Symbol..........................................OXIS

     The Company will not receive proceeds from these sales of common stock.

               Our common stock involves a high degree of risk.
                    See "Risk Factors" beginning on page 3.

     Neither the Securities and Exchange Commission nor any state securities
commission has approved or disapproved of these securities or passed upon the
adequacy or accuracy of this prospectus. Any representation to the contrary is a
criminal offense.

               The date of this prospectus is December 22, 2000."
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
